1,4-dihydroxyanthraquinone has been researched along with Glioma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Belej, D; Horvath, D; Huntosova, V; Joniova, J; Jurasekova, Z; Kozar, T; Miskovsky, P; Stanicova, J; Verebova, V | 1 |
1 other study(ies) available for 1,4-dihydroxyanthraquinone and Glioma
Article | Year |
---|---|
Deeper insights into the drug defense of glioma cells against hydrophobic molecules.
Topics: Anthracenes; Anthraquinones; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Nucleus; Cholesterol, LDL; DNA; Emodin; Glioma; Humans; Hydrophobic and Hydrophilic Interactions; Light; Molecular Docking Simulation; Perylene; Serum Albumin | 2016 |